The EBMT Benchmarking* reports for the period 2017-2021 are now available to qualifying Centres in their respective EBMTSHARE Google Drive.
A personalised email was sent to the Principal Investigators and/or Data Managers of the centres that qualified to receive the Benchmarking report with the instructions for the reports access.
Who receives the report?
Only centres that meet the following criteria will receive this report:
- Full membership of EBMT at the time of the transplantation
- During the 5-year period 2017–2021 at least 80% of the transplants reported in the Activity Survey for the centre were registered in the EBMT
- Meeting the annual minimum activity threshold of 10 first allogeneic transplants and/or 5 first autologous transplants as set out in the FACT-JACIE Standards.
The content of this year’s report is the same as the September 2022 exercise:
- 1-year follow up and 1-year survival analysis
- 1-year progression free survival (PFS)
- Day 100 Mortality and Day 100 follow up
Check your credentials!
Make sure you can access the Google Drive folder of your centre and that your credentials are valid and still working.
Instructions on how to access the report and recover your credentials can be found here.
Please remember that only the PI of each centre has access to the Google Drive folders.
National Registry Access
If you have already given consent for your national registry to have access to reports, this same consent will apply to this exercise.
If you haven’t and wish to give consent for your national registry to have access to reports, the centre PI should send an email to the address below requesting this. Please don’t forget to include your centre's CIC number.
Should you have any questions, please write to firstname.lastname@example.org
* Benchmarking (defined as “the process of comparing a practice’s performance with an external standard”) will provide transplant professionals with a means to assess how their unit is performing compared to the wider BMT community. In addition, it can reassure patients and payers with respect to the clinical performance and cost-effectiveness of their clinical BMT teams and services. Regulators see that benchmarking is an additional component to ensuring safe care of patients.